Severe Thrombocytopenia as a Predictor of Survival and Response to Hypomethylating Agents in Myelodysplastic Syndromes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
American Journal of Hematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Severe Thrombocytopenia as a Predictor of Survival and Response to Hypomethylating Agents in Myelodysplastic Syndromes: A Latin-American Cohort Of 212 Patients
Am. J. Hematol 2020 Aug 30;[EPub Ahead of Print], C Lazzarino, J Arbelbide, S Schuster, R Crisp, J Gonzalez, R Tavares, MA Perusini, M Di Stefano, N Pintos, D Espinosa, M Pimentel, M Rosenhain, JC Serrano, A Enrico, M Iastrebner, C BelliFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.